Ulcerative Colitis in Remission
In a study involving UC patients intolerant or allergic to 5-ASA who were in remission, 75% of patients had a positive response to VSL#3® administered for 12 months.
Original Articles of VSL#3® for the care of patients with UC
Tursi A et al: Med Sci Monit 2004;10:PI126-131.
Bibiloni R et al: Am J Gastroenterology 2005;100:1-8.
Venturi A et al: Ailment Pharmacol Ther 1999; 13:1103-1108.
Miele et al: Am J of Gastro 2009;104(2): 437-443.